Misdiagnosis in Fabry Disease

Journal of Pediatrics

Volumn 156, Issue 5, 2010, Pages 828-831

  Marchesoni, Cintia L ^a   Roa, Norma ^b   Pardal, Ana María ^a   Neumann, Pablo ^c   Cáceres, Guillermo ^d   Martínez, Pablo ^e   Kisinovsky, Isaac ^b   Bianchi, Silvia ^f   Tarabuso, Ana Lía ^g   Reisin, Ricardo C ^a  

^a HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^b Instituto Médico Quilmes   (Argentina)

^c HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^d Hospital Interzonal Pinamar   (Argentina)

^e Hospital Interzonal de Bahía Blanca   (Argentina)

^f Pediatric Service   (Argentina)

^g CEAL Centro Médico   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANHIDROSIS; ARTICLE; CHILD; CLINICAL EVALUATION; CONSULTATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; ENZYMATIC ASSAY; FABRY DISEASE; FEMALE; FOOD POISONING; HEMANGIOKERATOMA; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; ONSET AGE; PEDIATRICIAN; PETECHIA; PHYSICIAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RHEUMATIC FEVER; SCHOOL CHILD; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; CHILD; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FABRY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 77950603771     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2010.02.012     Document Type: Article

References (33)

1. Sweeley C.C., and Klionsky B. Fabry's disease: classification as a sphingolipidosis and partial characterization of a novel glycolipid. J Biol Chem 238 (1963) 3148-3150
2. Aerts J.M., Groener J.E., Kuiper S., Donker-Koopman W.E., Strijland A., Ottenhoff R., et al. Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci USA 105 (2008) 2812-2817
3. MacDermot K.D., Holmes A., and Minners A.H. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 38 (2001) 750-760
4. MacDermot K.D., Holmes A., and Minners A.H. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38 (2001) 769-775
5. Mehta A., Ricci R., Widmer U., Dehout F., Garcia de Lorenzo A., Kampmann C., et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34 (2004) 236-242
6. Hollak C.E., Vedder A.C., Linthorst G.E., and Aerts J.M. Novel therapeutic targets for the treatment of Fabry disease. Expert Opin Ther Targets 11 (2007) 821-833
7. Wraith J.E., Tylki-Szymanska A., Guffon N., Lien Y.H., Tsimaratos M., Vellodi A., et al. Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease. J Pediatr 152 (2008) 563-570
8. Ramaswami U., Whybra C., Parini R., Pintos-Morell G., Mehta A., Sunder-Plassmann G., et al. Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey. Acta Paediatr 95 (2006) 86-92
9. Ries M., Clarke J.T., Whybra C., Timmons M., Robinson C., Schlaggar B.L., et al. Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease. Pediatrics 118 (2006) 924-932
10. Masson C., Cissé I., Simon V., Insalaco P., and Audran M. Fabry disease: a review. Joint Bone Spine 71 (2004) 381-383
11. Desnick R.J., and Brady R.O. Fabry disease in childhood. J Pediatr 144 Suppl (2004) S20-S26
12. Liston E.H., Levine M.D., and Philippart M. Psychosis in Fabry disease and treatment with phenoxybenzamine. Arch Gen Psychiatry 29 (1973) 402-403
13. Grewal R.P. Psychiatric disorders in patients with Fabry's disease. Int J Psychiatry Med 23 (1993) 307-312
14. Sadek J., Shellhaas R., Camfield C.S., Camfield P.R., and Burley J. Psychiatric findings in four female carriers of Fabry disease. Psychiatr Genet 14 (2004) 199-201
15. Birklein F. Mechanisms of neuropathic pain and their importance in Fabry disease. Acta Paediatr Suppl 91 (2002) 34-37
16. Tan S.V., Lee P.J., Walters R.J., Mehta A., and Bostock H. Evidence for motor axon depolarization in Fabry disease. Muscle Nerve 32 (2005) 548-551
17. Hoffmann B., Beck M., Sunder-Plassmann G., Borsini W., Ricci R., Mehta A., et al. Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy-a retrospective analysis from the Fabry Outcome Survey. Clin J Pain 23 (2007) 535-542
18. Paira S.O., Roverano S., Iribas J.L., and Barceló H.A. Joint manifestations of Fabry's disease. Clin Rheumatol 11 (1992) 562-565
19. Manger B., Mengel E., and Schaefer R. Rheumatologic aspects of lysosomal storage diseases. Clin Rheumatol 26 (2007) 335-341
20. Atar D., Lehman W.B., and Grant A.D. Growing pains. Orthop Rev 20 (1991) 133-136
21. Hopkin R., Bissler J., Banikazemi M., Clarke L., Eng G., Germain D., et al. Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry. Pediatr Res 64 (2009) 550-555
22. Hoffmann B., Schwarz M., Mehta A., and Keshav S. Fabry Outcome Survey European Investigators. Gastrointestinal symptoms in 342 patients with Fabry disease: prevalence and response to enzyme replacement therapy. Clin Gastroenterol Hepatol 5 (2007) 1447-1453
23. Alfvén G. One hundred cases of recurrent abdominal pain in children: diagnostic procedures and criteria for a psychosomatic diagnosis. Acta Paediatr 92 (2003) 43-49
24. Apley J. The Child with Abdominal Pains. 2nd ed. (1975), Blackwell Scientific, Oxford, UK
25. Chitkara D.K., Rawat D.J., and Talley N.J. The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review. Am J Gastroenterol 100 (2005) 1868-1875
26. Lake A.M. Chronic abdominal pain in childhood: diagnosis and management. Am Fam Physician 59 (1999) 1823-1830
27. Frank F., Stricker T., Stallmach T., and Braegger C.P. Helicobacter pylori infection in recurrent abdominal pain. J Pediatr Gastroenterol Nutr 31 (2000) 424-427
28. Hyams J.S. Chronic abdominal pain caused by sorbitol malabsorption. J Pediatr 100 (1982) 772-773
29. Della Giovanna P. Del angioqueratoma a la enfermedad de Fabry. Dermatol Arg 4 (2004) 263-269
30. Möhrenschlager M., Braun-Falco M., Ring J., and Abeck D. Fabry disease: recognition and management of cutaneous manifestations. Am J Clin Dermatol 4 (2003) 189-196
31. Metha A. New developments in the management of Anderson-Fabry disease. QJM 95 (2002) 647-653
32. Larralde M., and Luna P. In: Wolff K., Goldsmith L.K., and Katz S.I. (Eds). Fabry disease in Fitzpatrick's Dermatology in General Medicine. 7th ed (2008), McGraw-Hill, New York 1281-1288
33. Wilcox W.R., Oliveira J.P., Hopkin R.J., Ortiz A., Banikazemi M., Feldt-Rasmussen U., et al. Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab 93 (2008) 112-128